Literature DB >> 18011

Thymic involution in murine graft-versus-host reaction. Epithelial injury mimicking human thymic dysplasia.

T A Seemayer, W S Lapp, R P Bolande.   

Abstract

Mild, moderate, and severe graft-versus-host (GVH) reactions were induced in four series of experiments in 71 CBA X A and C57BL/6 X A F1 hybrid mice. At regular intervals post-GVH reaction induction (Days 4-42), the animals were sacrificed, autopsied, and histologically studied. Visceral alterations of GVH reaction were recorded in the spleen, lymph nodes, liver, kidney, gut, and thymus. A spectrum of thymic changes was documented, ranging from obliteration of a definable cortex and medulla with loss of Hassall's corpuscles to marked involution with complete disappearance of the gland. Ultrastructural studies revealed damage to both lymphocytes and epithelial cells along with lymphocyte emperipolesis of epithelial cells, lymphocytolysis within epithelial cells, and accumulation of numerous autophagic vacuoles containing fragments of cellular debris within epithelial cells and histiocytes. The resemblance of these alterations to human thymic dysplasia as observed in primary immunodeficient conditions was striking. The theoretical implications of these studies for the pathogenesis of human congenital immunodeficiency states are considered.

Entities:  

Mesh:

Year:  1977        PMID: 18011      PMCID: PMC2032165     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Graft-versus-host induced immunosuppression: depressed T cell helper function in vitro.

Authors:  R Elie; W S Lapp
Journal:  Cell Immunol       Date:  1976-01       Impact factor: 4.868

2.  Radiosensitivity of the cortical and medullary lymphocytes in the thymus.

Authors:  O A TROWELL
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1961-11

3.  Graft-versus-host reaction (GVHR). A case report suggesting GVHR occurred as a result of maternofetal cell transfer.

Authors:  T M Grogan; D D Broughton; W F Doyle
Journal:  Arch Pathol       Date:  1975-06

Review 4.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

5.  Graft versus host reactions following transplantation of allogeneic hematopoietic cells.

Authors:  J H Kersey; H J Meuwissen; R A Good
Journal:  Hum Pathol       Date:  1971-09       Impact factor: 3.466

6.  Effect of lymphoid tissue transplants on the intensity of an existing graft-versus-host reaction.

Authors:  M Grushka; W S Lapp
Journal:  Transplantation       Date:  1974-02       Impact factor: 4.939

7.  Graft-versus-host disease after intrauterine and exchange transfusions for hemolytic disease of the newborn.

Authors:  R Parkman; D Mosier; I Umansky; W Cochran; C B Carpenter; F S Rosen
Journal:  N Engl J Med       Date:  1974-02-14       Impact factor: 91.245

8.  Soluble factors and the immune response: in vitro studies of the immunosuppression induced by the graft-versus-host reaction.

Authors:  E Parthenais; R Elie; W S Lapp
Journal:  Cell Immunol       Date:  1974-07       Impact factor: 4.868

9.  Immune restoration of mice immunosuppressed by a graft-vs.-host reaction.

Authors:  W S Lapp; A Wechsler; P A Kongshavn
Journal:  Cell Immunol       Date:  1974-03-30       Impact factor: 4.868

10.  An electron microscope study of lymphatic tissue in runt disease.

Authors:  L Weiss; A C Aisenberg
Journal:  J Cell Biol       Date:  1965-06       Impact factor: 10.539

View more
  24 in total

1.  Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function.

Authors:  M B Baker; R L Riley; E R Podack; R B Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

2.  Thymic epithelial injury in graft-versus-host reactions following adrenalectomy.

Authors:  T A Seemayer; W S Lapp; R P Bolande
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.

Authors:  R D Huby; G Janossy; I A Lampert
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

4.  Complete sequential regeneration of graft-vs.-host-induced severely dysplastic thymuses. Implications for the pathogenesis of chronic graft-vs.-host disease.

Authors:  T Ghayur; T A Seemayer; A Xenocostas; W S Lapp
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

Review 5.  Thymic non-lymphoid cells.

Authors:  D A Crouse; J B Turpen; J G Sharp
Journal:  Surv Immunol Res       Date:  1985

6.  Very Low Numbers of CD4+ FoxP3+ Tregs Expanded in Donors via TL1A-Ig and Low-Dose IL-2 Exhibit a Distinct Activation/Functional Profile and Suppress GVHD in a Preclinical Model.

Authors:  Sabrina Copsel; Dietlinde Wolf; Brandon Kale; Henry Barreras; Casey O Lightbourn; Cameron S Bader; Warren Alperstein; Norman H Altman; Krishna V Komanduri; Robert B Levy
Journal:  Biol Blood Marrow Transplant       Date:  2018-05-08       Impact factor: 5.742

7.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

8.  The thymus in patients with allogeneic bone marrow transplants.

Authors:  W E Beschorner; G M Hutchins; G J Elfenbein; G W Santos
Journal:  Am J Pathol       Date:  1978-07       Impact factor: 4.307

Review 9.  Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Authors:  C M Capitini; A A Chisti; C L Mackall
Journal:  J Intern Med       Date:  2009-08       Impact factor: 8.989

10.  Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

Authors:  Brile Chung; Eric P Dudl; Dullei Min; Lora Barsky; Nancy Smiley; Kenneth I Weinberg
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.